The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neurovascular Embolectomy Device Market Research Report 2025
Synopsis
Neurovascular embolectomy device is used during an embolectomy procedure. These devices are used for removal of emboli, obstructing the blood circulation, surgically. Usually, embolectomy is the least preferred option for treatment and other involved therapeutic options are anticoagulation and thrombolysis. Neurovascular device market has undergone a demand-shift with respect to products and techniques. Doctors want to adopt instruments and techniques that offer higher window for stroke treatment with high success rate and minimal post-surgical impact. This is supported by the fact that demand for bare platinum coils is growing at a higher pace in comparison to coated coils. This is mainly due to high costs of coated coils and their less improved clinical outcomes compared to bare platinum coils. Additionally, stroke treatment involves high healthcare expenditure that drives the focus on development of economical treatment techniques.
The global Neurovascular Embolectomy Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Neurovascular Embolectomy Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurovascular Embolectomy Device.
Report Scope
The Neurovascular Embolectomy Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurovascular Embolectomy Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurovascular Embolectomy Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific Corporation
Cook Medical
DePuy Synthes
Edwards Lifesciences Corporation
iVascular SLU
LeMaitre Vascular, Inc
Medtronic
Straub Medical AG
Teleflex Inc
Segment by Type
Aspiration Systems
Stent Retreival Systems
Segment by Application
Hospital
Medical Center
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurovascular Embolectomy Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurovascular Embolectomy Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Neurovascular embolectomy device is used during an embolectomy procedure. These devices are used for removal of emboli, obstructing the blood circulation, surgically. Usually, embolectomy is the least preferred option for treatment and other involved therapeutic options are anticoagulation and thrombolysis. Neurovascular device market has undergone a demand-shift with respect to products and techniques. Doctors want to adopt instruments and techniques that offer higher window for stroke treatment with high success rate and minimal post-surgical impact. This is supported by the fact that demand for bare platinum coils is growing at a higher pace in comparison to coated coils. This is mainly due to high costs of coated coils and their less improved clinical outcomes compared to bare platinum coils. Additionally, stroke treatment involves high healthcare expenditure that drives the focus on development of economical treatment techniques.
The global Neurovascular Embolectomy Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Neurovascular Embolectomy Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurovascular Embolectomy Device.
Report Scope
The Neurovascular Embolectomy Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurovascular Embolectomy Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurovascular Embolectomy Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific Corporation
Cook Medical
DePuy Synthes
Edwards Lifesciences Corporation
iVascular SLU
LeMaitre Vascular, Inc
Medtronic
Straub Medical AG
Teleflex Inc
Segment by Type
Aspiration Systems
Stent Retreival Systems
Segment by Application
Hospital
Medical Center
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurovascular Embolectomy Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurovascular Embolectomy Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Neurovascular Embolectomy Device Market Overview
1.1 Product Overview and Scope of Neurovascular Embolectomy Device
1.2 Neurovascular Embolectomy Device Segment by Type
1.2.1 Global Neurovascular Embolectomy Device Market Value Comparison by Type (2024-2030)
1.2.2 Aspiration Systems
1.2.3 Stent Retreival Systems
1.3 Neurovascular Embolectomy Device Segment by Application
1.3.1 Global Neurovascular Embolectomy Device Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Other
1.4 Global Neurovascular Embolectomy Device Market Size Estimates and Forecasts
1.4.1 Global Neurovascular Embolectomy Device Revenue 2019-2030
1.4.2 Global Neurovascular Embolectomy Device Sales 2019-2030
1.4.3 Global Neurovascular Embolectomy Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neurovascular Embolectomy Device Market Competition by Manufacturers
2.1 Global Neurovascular Embolectomy Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neurovascular Embolectomy Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neurovascular Embolectomy Device Average Price by Manufacturers (2019-2024)
2.4 Global Neurovascular Embolectomy Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurovascular Embolectomy Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurovascular Embolectomy Device, Product Type & Application
2.7 Neurovascular Embolectomy Device Market Competitive Situation and Trends
2.7.1 Neurovascular Embolectomy Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurovascular Embolectomy Device Players Market Share by Revenue
2.7.3 Global Neurovascular Embolectomy Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurovascular Embolectomy Device Retrospective Market Scenario by Region
3.1 Global Neurovascular Embolectomy Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neurovascular Embolectomy Device Global Neurovascular Embolectomy Device Sales by Region: 2019-2030
3.2.1 Global Neurovascular Embolectomy Device Sales by Region: 2019-2024
3.2.2 Global Neurovascular Embolectomy Device Sales by Region: 2025-2030
3.3 Global Neurovascular Embolectomy Device Global Neurovascular Embolectomy Device Revenue by Region: 2019-2030
3.3.1 Global Neurovascular Embolectomy Device Revenue by Region: 2019-2024
3.3.2 Global Neurovascular Embolectomy Device Revenue by Region: 2025-2030
3.4 North America Neurovascular Embolectomy Device Market Facts & Figures by Country
3.4.1 North America Neurovascular Embolectomy Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neurovascular Embolectomy Device Sales by Country (2019-2030)
3.4.3 North America Neurovascular Embolectomy Device Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neurovascular Embolectomy Device Market Facts & Figures by Country
3.5.1 Europe Neurovascular Embolectomy Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neurovascular Embolectomy Device Sales by Country (2019-2030)
3.5.3 Europe Neurovascular Embolectomy Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurovascular Embolectomy Device Market Facts & Figures by Country
3.6.1 Asia Pacific Neurovascular Embolectomy Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neurovascular Embolectomy Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Neurovascular Embolectomy Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neurovascular Embolectomy Device Market Facts & Figures by Country
3.7.1 Latin America Neurovascular Embolectomy Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neurovascular Embolectomy Device Sales by Country (2019-2030)
3.7.3 Latin America Neurovascular Embolectomy Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurovascular Embolectomy Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurovascular Embolectomy Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neurovascular Embolectomy Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neurovascular Embolectomy Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Neurovascular Embolectomy Device Sales by Type (2019-2030)
4.1.1 Global Neurovascular Embolectomy Device Sales by Type (2019-2024)
4.1.2 Global Neurovascular Embolectomy Device Sales by Type (2025-2030)
4.1.3 Global Neurovascular Embolectomy Device Sales Market Share by Type (2019-2030)
4.2 Global Neurovascular Embolectomy Device Revenue by Type (2019-2030)
4.2.1 Global Neurovascular Embolectomy Device Revenue by Type (2019-2024)
4.2.2 Global Neurovascular Embolectomy Device Revenue by Type (2025-2030)
4.2.3 Global Neurovascular Embolectomy Device Revenue Market Share by Type (2019-2030)
4.3 Global Neurovascular Embolectomy Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neurovascular Embolectomy Device Sales by Application (2019-2030)
5.1.1 Global Neurovascular Embolectomy Device Sales by Application (2019-2024)
5.1.2 Global Neurovascular Embolectomy Device Sales by Application (2025-2030)
5.1.3 Global Neurovascular Embolectomy Device Sales Market Share by Application (2019-2030)
5.2 Global Neurovascular Embolectomy Device Revenue by Application (2019-2030)
5.2.1 Global Neurovascular Embolectomy Device Revenue by Application (2019-2024)
5.2.2 Global Neurovascular Embolectomy Device Revenue by Application (2025-2030)
5.2.3 Global Neurovascular Embolectomy Device Revenue Market Share by Application (2019-2030)
5.3 Global Neurovascular Embolectomy Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific Corporation
6.1.1 Boston Scientific Corporation Corporation Information
6.1.2 Boston Scientific Corporation Description and Business Overview
6.1.3 Boston Scientific Corporation Neurovascular Embolectomy Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific Corporation Neurovascular Embolectomy Device Product Portfolio
6.1.5 Boston Scientific Corporation Recent Developments/Updates
6.2 Cook Medical
6.2.1 Cook Medical Corporation Information
6.2.2 Cook Medical Description and Business Overview
6.2.3 Cook Medical Neurovascular Embolectomy Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Cook Medical Neurovascular Embolectomy Device Product Portfolio
6.2.5 Cook Medical Recent Developments/Updates
6.3 DePuy Synthes
6.3.1 DePuy Synthes Corporation Information
6.3.2 DePuy Synthes Description and Business Overview
6.3.3 DePuy Synthes Neurovascular Embolectomy Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 DePuy Synthes Neurovascular Embolectomy Device Product Portfolio
6.3.5 DePuy Synthes Recent Developments/Updates
6.4 Edwards Lifesciences Corporation
6.4.1 Edwards Lifesciences Corporation Corporation Information
6.4.2 Edwards Lifesciences Corporation Description and Business Overview
6.4.3 Edwards Lifesciences Corporation Neurovascular Embolectomy Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Edwards Lifesciences Corporation Neurovascular Embolectomy Device Product Portfolio
6.4.5 Edwards Lifesciences Corporation Recent Developments/Updates
6.5 iVascular SLU
6.5.1 iVascular SLU Corporation Information
6.5.2 iVascular SLU Description and Business Overview
6.5.3 iVascular SLU Neurovascular Embolectomy Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 iVascular SLU Neurovascular Embolectomy Device Product Portfolio
6.5.5 iVascular SLU Recent Developments/Updates
6.6 LeMaitre Vascular, Inc
6.6.1 LeMaitre Vascular, Inc Corporation Information
6.6.2 LeMaitre Vascular, Inc Description and Business Overview
6.6.3 LeMaitre Vascular, Inc Neurovascular Embolectomy Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 LeMaitre Vascular, Inc Neurovascular Embolectomy Device Product Portfolio
6.6.5 LeMaitre Vascular, Inc Recent Developments/Updates
6.7 Medtronic
6.6.1 Medtronic Corporation Information
6.6.2 Medtronic Description and Business Overview
6.6.3 Medtronic Neurovascular Embolectomy Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medtronic Neurovascular Embolectomy Device Product Portfolio
6.7.5 Medtronic Recent Developments/Updates
6.8 Straub Medical AG
6.8.1 Straub Medical AG Corporation Information
6.8.2 Straub Medical AG Description and Business Overview
6.8.3 Straub Medical AG Neurovascular Embolectomy Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Straub Medical AG Neurovascular Embolectomy Device Product Portfolio
6.8.5 Straub Medical AG Recent Developments/Updates
6.9 Teleflex Inc
6.9.1 Teleflex Inc Corporation Information
6.9.2 Teleflex Inc Description and Business Overview
6.9.3 Teleflex Inc Neurovascular Embolectomy Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teleflex Inc Neurovascular Embolectomy Device Product Portfolio
6.9.5 Teleflex Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurovascular Embolectomy Device Industry Chain Analysis
7.2 Neurovascular Embolectomy Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurovascular Embolectomy Device Production Mode & Process
7.4 Neurovascular Embolectomy Device Sales and Marketing
7.4.1 Neurovascular Embolectomy Device Sales Channels
7.4.2 Neurovascular Embolectomy Device Distributors
7.5 Neurovascular Embolectomy Device Customers
8 Neurovascular Embolectomy Device Market Dynamics
8.1 Neurovascular Embolectomy Device Industry Trends
8.2 Neurovascular Embolectomy Device Market Drivers
8.3 Neurovascular Embolectomy Device Market Challenges
8.4 Neurovascular Embolectomy Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
